Celgene Corporation
Venture Capital
Global biopharmaceutical company focused on cancer and immunology drugs; acquired by Bristol-Myers Squibb in 2019. Made strategic biotech venture investments.
Summit, United States · 11+ investments
Early Stage
Growth
Late Stage
Biotech
Oncology
- Headquarters
- Summit, United States
- Founded
- 1986
- Website
- celgene.com
- Total Investments
- 11
- Last Investment
- Mar 2021
- Geographic Focus
- United States
Investment Thesis
Strategic co-investments and partnerships in oncology, immunology, and CRISPR therapeutics to complement internal drug development pipeline.
Celgene Corporation is a Venture Capital firm based in Summit, United States. It has made 11 investments in Biotech and Oncology.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.